Malignant transformation of metastatic giant cell tumor of bone in a patient undergoing denosumab treatment: A case report - Journal of Orthopaedic Science
Postpartum Treatment of Metastatic Recurrent Giant Cell Tumor of Capitate Bone of Wrist | MDedge Surgery
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone – Multicenter analysis outside clinical trial - European Journal of Surgical Oncology
Flowchart for selection of patients and data collection. GCTB:... | Download Scientific Diagram
Giant cell tumour of the bone treated with denosumab: How has the blood supply and oncological prognosis of the tumour changed? - ScienceDirect
Cancers | Free Full-Text | Current Concepts in the Treatment of Giant Cell Tumors of Bone | HTML
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab | BMC Cancer | Full Text
The role of Denosumab in joint preservation for patients with giant cell tumour of bone | The Bone & Joint Journal
Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial - Annals of Oncology
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? - European Journal of Cancer
Study design for administration of denosumab to patients with giant... | Download Scientific Diagram
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study - The Lancet Oncology
Denosumab Safety and Efficacy in Giant Cell Tumor of Bone (GCTB): Interim Results From a Phase 2 study Sant Chawla, 1 Jean-Yves Blay, 2 Javier Martin Broto, - ppt download
H3F3A‐mutated giant cell tumour of bone without giant cells—clinical presentation, radiology and histology of three cases - Leinauer - 2021 - Histopathology - Wiley Online Library
Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence - Journal of Orthopaedic Science